ADVIA CENTAUR TOXOPLASMA IGG (TOXO G)— 510(k) K102681

Name: FDA 510(k) clearance K102681
Creator: U.S. Food and Drug Administration
Published: 2011-05-04

Substantially Equivalent

Siemens Healthcare Diagnostics, Inc.

FDA 510(k) clearance K102681 for ADVIA CENTAUR TOXOPLASMA IGG (TOXO G), Substantially Equivalent on 2011-05-04. Applicant: Siemens Healthcare Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Siemens Healthcare Diagnostics, Inc.
Product code: Code LGD
Device class: Class 2
Regulation: 21 CFR 866.3780
Advisory panel: Microbiology
Date received: 2010-09-17
Decision date: 2011-05-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LGD

view all

K242022 — Access Toxo IgG2025-03-28
K242095 — Access Toxo IgM II2024-10-11
K233932 — Alinity i Toxo IgM2024-08-30
K210596 — ARCHITECT Toxo IgG2022-05-19
K162678 — Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl2017-06-23

More clearances from Siemens Healthcare Diagnostics, Inc.

view all

K253528 — Atellica IM CA 19-9 II2026-08-10
K261364 — Atellica CH Acetaminophen 2 (ACTM)2026-07-24
K251998 — Atellica CH Diazo Total Bilirubin (D_TBil)2026-02-27
K251543 — Atellica® IM TSH3-Ultra II (TSH3ULII)2026-02-06
K251630 — Atellica IM Total PSA II (tPSAII)2026-01-05

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.